Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multiple myeloma.

× No keyword cloud information.

422 in total

1. Myeloma as a model for the process of metastasis: implications for therapy.

Authors: Irene M Ghobrial
Journal: Blood Date: 2012-04-24 Impact factor: 22.113

2. Novel treatment paradigm for elderly patients with multiple myeloma.

Authors: Antonio Palumbo; Valeria Magarotto
Journal: Am J Blood Res Date: 2011-09-18

3. Review.

Authors: Christopher B O'Brien
Journal: Gastroenterol Hepatol (N Y) Date: 2008-08

4. Mesenteric amyloid deposition as the initial presentation of multiple myeloma.

Authors: Mehrnaz Asadi
Journal: BMJ Case Rep Date: 2011-02-02

5. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women.

Authors: Ola Landgren; S Vincent Rajkumar; Ruth M Pfeiffer; Robert A Kyle; Jerry A Katzmann; Angela Dispenzieri; Qiuyin Cai; Lynn R Goldin; Neil E Caporaso; Joseph F Fraumeni; William J Blot; Lisa B Signorello
Journal: Blood Date: 2010-04-26 Impact factor: 22.113

6. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.

Authors: Ola Landgren; Robert A Kyle; Ruth M Pfeiffer; Jerry A Katzmann; Neil E Caporaso; Richard B Hayes; Angela Dispenzieri; Shaji Kumar; Raynell J Clark; Dalsu Baris; Robert Hoover; S Vincent Rajkumar
Journal: Blood Date: 2009-01-29 Impact factor: 22.113

Review 7. Myeloma and Bone Disease.

Authors: Cristina Panaroni; Andrew J Yee; Noopur S Raje
Journal: Curr Osteoporos Rep Date: 2017-10 Impact factor: 5.096

Review 8. CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma.

Authors: Joseph D Malaer; Porunelloor A Mathew
Journal: Am J Cancer Res Date: 2017-08-01 Impact factor: 6.166

9. Decreased affinity of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL) D269H/E195R to osteoprotegerin (OPG) overcomes TRAIL resistance mediated by the bone microenvironment.

Authors: Matthieu C J Bosman; Carlos R Reis; Jan J Schuringa; Edo Vellenga; Wim J Quax
Journal: J Biol Chem Date: 2013-11-26 Impact factor: 5.157

10. PEGylation of vesicular stomatitis virus extends virus persistence in blood circulation of passively immunized mice.

Authors: Mulu Z Tesfay; Amber C Kirk; Elizabeth M Hadac; Guy E Griesmann; Mark J Federspiel; Glen N Barber; Stephen M Henry; Kah-Whye Peng; Stephen J Russell
Journal: J Virol Date: 2013-01-16 Impact factor: 5.103